Ortoma AB Stock: price and insider trades · Sweden

Ortoma AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. Over the twelve months to 30 October 2026, 14 filings were filed, from 6 insiders.

Open-market activity splits into 8 purchases totalling €475k and 1 sale totalling €21k; 4 insiders sit on the buying side and 1 insider on the selling side. Taken together, the purchases exceed the sales by €454k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 3 board members and 1 chief executive. Biggest ticket of the year: €226k, bought by Peter Möller and made public on 20 April 2026.

In all, 1 purchase was made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase dates back some time: it was published 202 days ago, on 20 April 2026. Typically, a trade is published a median of 3 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades.

For context, the typical company on the same exchange (median of 1,035 companies) published 9 filings over the same period, against 14 filings here. Since 2016, the database holds 51 purchases and 18 sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.